Gulnaz Dadashova

Gulnaz Dadashova
Gulnaz Dadashova.jpg Gulnaz Dadashova.jpg
Native name	Gülnaz Mahir qızı Dadaşova
Born	Baku, Azerbaijan
🏳️ Citizenship	Azerbaijan
💼 Occupation
👶 Children	2
🥚 Twitter	Twitter=

label65 = 👍 Facebook

Gulnaz Dadashova (Azerbaijani: Gülnaz Mahir qızı Dadaşova) is an Azerbaijani scientist, professor, doctor of medical sciences. Currently, she is the director of the Scientific Research Cardiology Institute named after J. Abdullayev.

Early life and education

Dadashova was born into a family of teachers in Baku.

She completed her secondary education at school No. 191, where she received a medal upon graduation. She attended the treatment-prophylaxis faculty of Azerbaijan Medical University from 1992 to 1998, graduating with a bachelor's degree. She carried out her internship in cardiology at the Baku Railway Hospital from 1999 to 2000. Between 2002 and 2005, she completed a post-graduate degree at the department of clinical pharmacology of Azerbaijan Medical University. She received the scientific degree of Doctor of Philosophy in Medical Sciences in 2008 after successfully defending her research on "Optimization of treatment of arterial hypertension in postmenopausal women."

In 2016, she received the title of associate professor. In 2018, she defended her scientific work "Gender characteristics of chronic heart failure, possibilities of improvement of diagnosis and drug treatment, determination of prognosis and survival predictions" and received the scientific degree of Doctor of Medical Sciences.

Dadashova entered the doctor-cardiologist specialty at the University of Zurich, Switzerland on master's degree in 2019, graduating in 2022. She subsequently completed the Postgraduate Course of Heart Failure (PCHF) at the same university.

Dadashova knows Russian and English.

Personal life

Dashova is married and has 2 children.

Career

Dadashova began her career in 2006 as a senior laboratory assistant at the Scientific Research Institute of Cardiology named after J. Abdullayev, and since 2014 she has continued her work as a senior researcher in the heart failure department. On September 21, 2018, she was appointed the director of that institute and currently holds that position.

At the same time, since 2007, she has been conducting lectures on the subject of Internal Medicine at the Department of the Clinical Pharmacology of Azerbaijan Medical University, since 2019 at the Department of III Internal Medicine of Azerbaijan Medical University at the English department and at the Baku branch of Sechenov First Moscow State Medical University.

Scientific career

Dadashova is the author of about 100 scientific works. She has acted as a speaker at a number of local and international scientific conferences.

She performed scientific research on gender differences in the renin-angiotensin-aldosterone system in patients with arterial hypertension and their relationship with humoral factors, gender characteristics of risk factors for developmentTemplate:Of what, age and gender differences in the severity and genesis of chronic heart failure, and conducted a study on the effect of moxonidine and the combination of moxonidine with ivabradine on insulin resistance parameters in patients with metabolic syndrome. She also conducted scientific research on the gender characteristics of the clinical and psycho-emotional condition of patients with chronic heart failure.

Building on this research, Dadashova also studied gender and age differences in the treatment of chronic heart failure at the observational hospital stage and gender differences in the dynamics of the clinical-functional and psycho-emotional state of the heart, morphological and functional parameters in patients with chronic heart failure after myocardial infarction against the background of different drug treatment options, and morpho-functional parameters in patients with chronic heart failure after myocardial infarction. During her scientific activity, she studied the features of the course of arterial hypertension in postmenopausal women and the hemodynamic and metabolic effects of complex therapy with moxonidine and hormonal replacement therapy in postmenopausal women with hypertension.

From 2016 to 2017, she was the chief coordinator of the OPTIMIZE-HF registry in Azerbaijan, a multi-national project organized by the European Society of Cardiology. She is also the head of the "Cardiovascular Pharmacology" working group at the Azerbaijan Cardiology Society (ACS).

Dadashova is the author and co-author of a number of textbooks, methodical materials, and a number of monographs, including "Современные Аспекты Хронической Сердечной Недостаточности" (

Part of a series on
Translation
Types
Legal Literary Bible Quran Linguistic validation Medical Regulatory Technical Interpretation Cultural Word-for-word vs. Sense-for-sense
Theory
Translation studies Skopos theory Translation project Translation criticism Dynamic and formal equivalence Contrastive linguistics
Technologies
CAT Machine translation Mobile (machine) translation Dubbing Subtitling Pre-editing Postediting Multimedia translation
Localization
Glocalization Internationalization and localization Language localisation Game localization Dub localization
Institutional
Associations Awards Organizations Schools
Related topics
Transcription Transliteration Video relay service (VRS) Telephone interpreting Language barrier Fan translation Fansub Fandub Journalistic translation Books and magazines on translation Bible translations by language Translated books Translators

), published in Moscow in 2022.

References

This article "Gulnaz Dadashova" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Gulnaz Dadashova. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.

---